[SCHEDULE 13G] Hinge Health, Inc. SEC Filing

Rhea-AI Filing Summary

Coatue and affiliated entities report a significant passive stake in Hinge Health's Class A stock. The filing discloses aggregate beneficial ownership of 2,960,200 shares by Coatue Management and Philippe Laffont, equal to 9.9% of the Class A shares. Two affiliated vehicles are separately disclosed: Coatue Growth Fund IV LP holds 2,401,696 shares (8.1%) and Coatue US 70 LLC holds 2,300,512 shares (7.9%). The reported shares include those directly held and those issuable upon conversion of Class B common stock, and all reported holdings are shown as shared voting and dispositive power with no sole voting or sole dispositive power.

Positive

• Material stake disclosed: Coatue-related reporting persons hold 2,960,200 Class A shares representing 9.9% of the class.
• Transparency on composition: Filing specifies that reported shares include those issuable upon conversion of Class B common stock.

Negative

• No sole voting or dispositive power: All reported shares are shown with shared voting and shared dispositive power, indicating no unilateral control by a single reporting person.

Insights

Financial Analyst

Coatue's near-10% stake is material and could influence market perception but does not imply sole control.

The Schedule 13G shows Coatue-related entities and Philippe Laffont beneficially own 2.96 million Class A shares (9.9%). For investors, a sub-10% passive disclosure signals meaningful economic exposure without an expressed intent to exert control. The filing clarifies that ownership includes shares issuable upon conversion of Class B stock, which can affect dilution and voting calculations. Shared voting and dispositive power indicates coordination among affiliates rather than unilateral control, so corporate governance outcomes remain subject to broader shareholder composition.

Corporate Governance Expert

Material ownership is disclosed but absence of sole voting power limits immediate governance impact.

The report documents shared voting and dispositive authority over the disclosed shares and explicitly shows zero sole voting or dispositive power across reporting persons. That structure suggests Coatue acts in concert across advisory clients and funds. While a nearly 10% economic stake is noteworthy, the lack of sole voting control means any board or strategic influence would likely require cooperation with other shareholders or formal engagement declared in future filings.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Hinge Health, Inc.

(Name of Issuer)

Class A Common Stock, par value $0.00001

(Title of Class of Securities)

433313103

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 433313103

1

Names of Reporting Persons

Coatue Management, L.L.C.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,960,200.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,960,200.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,960,200.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

IA, OO

SCHEDULE 13G

CUSIP No. 433313103

1

Names of Reporting Persons

Philippe Laffont

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,960,200.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,960,200.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,960,200.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.9 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

CUSIP No. 433313103

1

Names of Reporting Persons

Coatue Growth Fund IV LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,401,696.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,401,696.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,401,696.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.1 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. 433313103

1

Names of Reporting Persons

Coatue US 70 LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 2,300,512.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 2,300,512.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,300,512.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.9 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Hinge Health, Inc.
(b)	Address of issuer's principal executive offices: 455 MARKET STREET, SUITE 700, SAN FRANCISCO, CA, 94105
Item 2.
(a)	Name of person filing: Coatue Management, L.L.C. Philippe Laffont Coatue Growth Fund IV LP Coatue US 70 LLC
(b)	Address or principal business office or, if none, residence: Coatue Management, L.L.C. 9 West 57th Street New York, New York 10019 Philippe Laffont c/o Coatue Management, L.L.C. 9 West 57th Street New York, New York 10019 Coatue Growth Fund IV LP c/o Coatue Management, L.L.C. 9 West 57th Street New York, New York 10019 Coatue US 70 LLC c/o Coatue Management, L.L.C. 9 West 57th Street New York, New York 10019
(c)	Citizenship: Coatue Management, L.L.C. - Delaware Philippe Laffont - United States of America Coatue Growth Fund IV LP - Delaware Coatue US 70 LLC - Delaware
(d)	Title of class of securities: Class A Common Stock, par value $0.00001
(e)	CUSIP No.: 433313103
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Coatue Management, L.L.C. - 2,960,200 Philippe Laffont - 2,960,200 Coatue Growth Fund IV LP - 2,401,696 Coatue US 70 LLC - 2,300,512 The number of shares of Class A Common Stock reported herein reflects the number of shares of Common Stock directly held and issuable upon conversion of Class B Common Stock.
(b)	Percent of class: Coatue Management, L.L.C. - 9.9% Philippe Laffont - 9.9% Coatue Growth Fund IV LP - 8.1% Coatue US 70 LLC - 7.9%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Coatue Management, L.L.C. - 0 Philippe Laffont - 0 Coatue Growth Fund IV LP - 0 Coatue US 70 LLC - 0
	(ii) Shared power to vote or to direct the vote: Coatue Management, L.L.C. - 2,960,200 Philippe Laffont - 2,960,200 Coatue Growth Fund IV LP - 2,401,696 Coatue US 70 LLC - 2,300,512
	(iii) Sole power to dispose or to direct the disposition of: Coatue Management, L.L.C. - 0 Philippe Laffont - 0 Coatue Growth Fund IV LP - 0 Coatue US 70 LLC - 0
	(iv) Shared power to dispose or to direct the disposition of: Coatue Management, L.L.C. - 2,960,200 Philippe Laffont - 2,960,200 Coatue Growth Fund IV LP - 2,401,696 Coatue US 70 LLC - 2,300,512
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. All securities reported in this Schedule 13G are owned by advisory clients of Coatue Management, L.L.C. None of the advisory clients, other than Coatue Growth Fund IV LP and Coatue US 70 LLC, individually owns more than 5% of the outstanding shares of Class A Common Stock, par value $0.00001 per share, of the issuer. Coatue US 70 LLC is owned by advisory clients of Coatue Management, L.L.C., which individually hold less than 5% of the outstanding shares of Class A Common Stock of the issuer.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. Please see Exhibit B attached hereto.
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Coatue Management, L.L.C.

Signature:	/s/ Philippe Laffont
Name/Title:	Philippe Laffont/Authorized Signatory
Date:	08/14/2025

Philippe Laffont

Signature:	/s/ Philippe Laffont
Name/Title:	Philippe Laffont
Date:	08/14/2025

Coatue Growth Fund IV LP

Signature:	By: Coatue Growth Fund IV GP LLC, it general partner, By: /s/ Philippe Laffont
Name/Title:	Philippe Laffont/Authorized Signatory
Date:	08/14/2025

Coatue US 70 LLC

Signature:	By: Coatue Management, L.L.C., its investment manager, By: /s/ Philippe Laffont
Name/Title:	Philippe Laffont/Authorized Signatory
Date:	08/14/2025

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.

Exhibit Information

Exhibit A - Joint Filing Agreement Exhibit B - Control Person Identification

FAQ

What stake in Hinge Health (HNGE) does Coatue report?

Coatue Management and affiliated reporting persons disclose ownership of 2,960,200 Class A shares, representing 9.9% of the Class A stock.

How many shares does Coatue Growth Fund IV LP hold in Hinge Health (HNGE)?

Coatue Growth Fund IV LP is reported to beneficially own 2,401,696 shares, equal to 8.1% of the Class A shares.

Does any reporting person have sole voting control over the Hinge Health shares?

No. The filing states 0 sole voting power and lists all reported holdings under shared voting and shared dispositive power.

Are the reported shares only directly held Class A shares?

No. The filing notes the reported number includes shares directly held and shares issuable upon conversion of Class B common stock.

Which Coatue entities are named in the Schedule 13G for Hinge Health (HNGE)?

The filing names Coatue Management, L.L.C., Philippe Laffont, Coatue Growth Fund IV LP, and Coatue US 70 LLC as reporting persons.